Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
Crossref DOI link: https://doi.org/10.1038/bcj.2015.90
Published Online: 2015-10-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guglielmelli, P
Rotunno, G
Fanelli, T
Pacilli, A
Brogi, G
Calabresi, L
Pancrazzi, A
Vannucchi, A M
,
Text and Data Mining valid from 2015-10-16
Version of Record valid from 2015-10-16
Article History
First Online: 16 October 2015
Competing interests
: The authors declare no conflict of interest.